01 · Market Intelligence · Analysis type · 43 published
Who controls which cohort, and on what evidence. Drug-by-drug commercial posture, prescribing share and payer positioning.
A 24–32 page PDF analyst brief, an editable Excel model, and a PowerPoint readout, with a 45-minute analyst call included.
Every figure is cited to a live PMID, ClinicalTrials.gov ID or URL at the point of writing, cross-checked against the source, and re-checked in an independent audit pass.
Yes. Intake captures your indication, comparators, market and the specific commercial question. A scoping call confirms scope before research begins.